Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Cytomegalovirus Infections Following CAR T-Cell Therapy: A Systematic Review and Meta-Analysis

Poorva Bindal, Marcela Banegas, Rodrigo Paredes, Maria Jose Hernandez Woodbine, Pushan Aggarwal, Jon E. Arnason, Carolyn D Alonso

Blood (2024) 144 (Supplement 1): 2407.

https://doi.org/10.1182/blood-2024-208855

Published: 2024

Journal Articles

Advances in CD137-Enriched Adoptive T Cell Therapy for Acute Myeloid Leukemia Via Ex Vivo Immune Cell Priming with DC/AML Fusion Vaccine

Blood (2024) 144 (Supplement 1): 4817.

https://doi.org/10.1182/blood-2024-208563

Published: 2024

Journal Articles

Characteristics and Clinical Outcomes of Patients with Myeloid Malignancies and Cohesin Mutations

Maria Rita Khouri, Bofei Wang, Poorva Bindal, Sakiko Suzuki, Lloyd Hutchinson, Laurie K Pearson, Andrew Gillis-Smith, Jan Cerny, Muthalagu Ramanathan, Jonathan M. Gerber, Shyam Ajay Patel

Blood (2024) 144 (Supplement 1): 1553.

https://doi.org/10.1182/blood-2024-201680

Published: 2024

Journal Articles

Infectious Complications in B-Cell Non-Hodgkin Lymphoma (NHL) Patients Treated with Bispecific Antibody Therapy (BsAb) As Compared to Chimeric Antigen Receptor T-Cell Therapy (CAR-T)

Genevieve M Gerhard, Robert A. Redd, Poorva Bindal, Carolyn D Alonso, Rushad Patell, Michael Leukam, Jon E. Arnason, Matthew Weinstock, Gottfried von Keudell

Blood (2024) 144 (Supplement 1): 6554.

https://doi.org/10.1182/blood-2024-199156

Published: 2024

Journal Articles

Late Infectious Complications of Chimeric Antigen Receptor T-Cell Therapy Beyond One Year

Sirui Ma, Poorva Bindal, Caitlin Trottier, Pavania Elavalakanar, Laura Dodge, Emma K Logan, Jessica Liegel, Jon E. Arnason, Carolyn D Alonso

Blood (2024) 144 (Supplement 1): 7789.

https://doi.org/10.1182/blood-2024-209567

Published: 2024

Journal Articles

4-1bb Enrichment Enhances Adoptive T Cell Therapy for Hematological Malignancies Using a Novel Approach for Ex Vivo Immune Cell Priming with DC/Tumor Fusion Vaccine

Kathrine S Rallis, Jessica Liegel, Giulia Cheloni, Poorva Bindal, Isabella Saldarriaga, Junyan Zhang, Georges Chedid, Joseph Abirached, John G. Clohessy, Sophia Adamia, Kai W Wucherpfennig, Donald Kufe, Jacalyn Rosenblatt, David Avigan

Blood (2023) 142 (Supplement 1): 2066.

https://doi.org/10.1182/blood-2023-182381

Published: 2023

Journal Articles

BCMA-Directed CAR-T Cell Therapy Is Associated with a Higher Risk of Infections: A Systematic Review and Meta-Analysis

Poorva Bindal, Marcela Banegas, Rodrigo Paredes, Maria Jose Hernandez, Pushan Aggarwal, Jon E. Arnason, Carolyn Alonso

Blood (2023) 142 (Supplement 1): 6917.

https://doi.org/10.1182/blood-2023-189225

Published: 2023

Journal Articles

Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease

Blood (2023) 141 (24): 2932–2943.

https://doi.org/10.1182/blood.2022019107

Published: 2023

Includes: Supplemental data

Journal Articles

Clonal Myeloid Disorders Following CAR T-Cell Therapy

Michael J. Andersen, Jr., Poorva Bindal, Phillip Michaels, Pavania Elavalakanar, Ajoy L. Dias, Jon E. Arnason, Rushad Patell

Blood (2022) 140 (Supplement 1): 10985–10986.

https://doi.org/10.1182/blood-2022-170430

Published: 2022

Journal Articles

G-CSF Administration Is Associated with Worse Treatment Response and Survival after CAR T-Cell Therapy

Poorva Bindal, Pavania Elavalakanar, Caitlin A. Trottier, Laura E. Dodge, Emma K. Logan, David J. Sermer, Michael Leukam, Matthew J Weinstock, Robin M. Joyce, Jessica Liegel, Jacalyn Rosenblatt, David Avigan, Carolyn D. Alonso, Jon E. Arnason

Blood (2022) 140 (Supplement 1): 5238–5240.

https://doi.org/10.1182/blood-2022-167976

Published: 2022

Journal Articles

Treatment with DC/AML Fusion Vaccine and CD3xCD123 Bi-Specific T-Cell Engager (CD123-CODV-TCE) for Treatment of Acute Myeloid Leukemia

Dina Stroopinsky, Anita G. Koshy, Jessica J. Liegel, Myrna Nahas, Giulia Cheloni, Joshua Hauser, Daniela Torres, Poorva Bindal, Maryam Rahimian, Lina Bisharat, Paula Fraenkel, Ozlem Yildirim, Helene Bonnevaux, Stephane Guerif, Donald Kufe, Jacalyn Rosenblatt, David Avigan

Blood (2021) 138 (Supplement 1): 904.

https://doi.org/10.1182/blood-2021-148219

Published: 2021

Journal Articles

Phase II Clinical Trial of Abatacept for Steroid-Refractory Chronic Graft Versus Host Disease

Blood (2021) 138 (Supplement 1): 264.

https://doi.org/10.1182/blood-2021-148343

Published: 2021

Journal Articles

Post-Transplant Vaccination with a Personalized Dendritic Cell/AML Fusion Cell Vaccine for Prevention of Relapse

Blood (2021) 138 (Supplement 1): 2830.

https://doi.org/10.1182/blood-2021-154166

Published: 2021

Journal Articles

Synergism between CAR-T Cells and a Personalized Tumor Vaccine in Hematological Malignances

Giulia Cheloni, Marzia Capelletti, Daniela Torres, Poorva Bindal, Jessica J. Liegel, Dina Stroopinsky, Lina Bisharat, Maryam Rahimian, Seo Yeon Yoo, Joshua Hauser, Anita G. Koshy, Kenel Dufort, John G. Clohessy, Donald Kufe, Maria Themeli, Jacalyn Rosenblatt, Michel Sadelain, David Avigan

Blood (2021) 138 (Supplement 1): 737.

https://doi.org/10.1182/blood-2021-150307

Published: 2021

Journal Articles

Profiling the Peripheral Blood Immune Cell Repertoire in Large-B Cell Lymphoma Patients Treated with CD19 CAR-T

Giulia Cheloni, Eleni Kanata, Dina Stroopinsky, Dimitra Karagkouni, Jessica J. Liegel, Daniela Torres, Joshua Hauser, Poorva Bindal, Anita G. Koshy, Yered Pita-Juarez, Adrian Bot, Mike Mattie, Justin Chou, Jacalyn Rosenblatt, David Avigan, Ioannis Vlachos

Blood (2021) 138 (Supplement 1): 2786.

https://doi.org/10.1182/blood-2021-151459

Published: 2021

Journal Articles

Vaccination with a Personalized Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in a Phase 1 Clinical Trial

Blood (2020) 136 (Supplement 1): 10.

https://doi.org/10.1182/blood-2020-141634

Published: 2020

Journal Articles

Postdischarge thrombosis and hemorrhage in patients with COVID-19

Rushad Patell, Thomas Bogue, Anita Koshy, Poorva Bindal, Mwanasha Merrill, William C. Aird, Kenneth A. Bauer, Jeffrey I. Zwicker

Blood (2020) 136 (11): 1342–1346.

https://doi.org/10.1182/blood.2020007938

Published: 2020

Includes: Supplemental data

NARROW

Cytomegalovirus Infections Following CAR T-Cell Therapy: A Systematic Review and Meta-Analysis

Advances in CD137-Enriched Adoptive T Cell Therapy for Acute Myeloid Leukemia Via Ex Vivo Immune Cell Priming with DC/AML Fusion Vaccine

Characteristics and Clinical Outcomes of Patients with Myeloid Malignancies and Cohesin Mutations

Infectious Complications in B-Cell Non-Hodgkin Lymphoma (NHL) Patients Treated with Bispecific Antibody Therapy (BsAb) As Compared to Chimeric Antigen Receptor T-Cell Therapy (CAR-T)

Late Infectious Complications of Chimeric Antigen Receptor T-Cell Therapy Beyond One Year

4-1bb Enrichment Enhances Adoptive T Cell Therapy for Hematological Malignancies Using a Novel Approach for Ex Vivo Immune Cell Priming with DC/Tumor Fusion Vaccine

BCMA-Directed CAR-T Cell Therapy Is Associated with a Higher Risk of Infections: A Systematic Review and Meta-Analysis

Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease

Clonal Myeloid Disorders Following CAR T-Cell Therapy

G-CSF Administration Is Associated with Worse Treatment Response and Survival after CAR T-Cell Therapy

Treatment with DC/AML Fusion Vaccine and CD3xCD123 Bi-Specific T-Cell Engager (CD123-CODV-TCE) for Treatment of Acute Myeloid Leukemia

Phase II Clinical Trial of Abatacept for Steroid-Refractory Chronic Graft Versus Host Disease

Post-Transplant Vaccination with a Personalized Dendritic Cell/AML Fusion Cell Vaccine for Prevention of Relapse

Synergism between CAR-T Cells and a Personalized Tumor Vaccine in Hematological Malignances

Profiling the Peripheral Blood Immune Cell Repertoire in Large-B Cell Lymphoma Patients Treated with CD19 CAR-T

Vaccination with a Personalized Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in a Phase 1 Clinical Trial

Postdischarge thrombosis and hemorrhage in patients with COVID-19

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only